Glaukos has a total of 788 patents globally, out of which 348 have been granted. Of these 788 patents, more than 50% patents are active. The United States of America is where Glaukos has filed the maximum number of patents, followed by Europe (EPO) and Japan. Parallelly, The United States of America seems to be the main focused R&D center, and also USA is the origin country of Glaukos.
Glaukos was founded in the year 1998. Glaukos is an ophthalmic medical technology and pharmaceutical company focused on developing and commercializing novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases.
Do read about some of the most popular patents of Glaukos which have been covered by us in this article and also you can find Glaukos patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Glaukos patent portfolio.
How many patents does Glaukos have?
Glaukos has a total of 788 patents globally. These patents belong to 150 unique patent families. Out of 788 patents, 399 patents are active.
How Many Patents did Glaukos File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
|Year of Patents Filing or Grant||Glaukos Applications Filed||Glaukos Patents Granted|
How many Glaukos patents are Alive/Dead?
How Many Patents did Glaukos File in Different Countries?
Countries in which Glaukos Filed Patents
|United States Of America||276|
|Hong Kong (S.A.R.)||5|
Where are the Research Centers of Glaukos Patents Located?
10 Best Glaukos Patents
US20050049578A1 is the most popular patent in the Glaukos portfolio. It has received 422 citations so far from companies like Neurosystec Corporation, Fujitsu Limited, and Alcon.
Below is the list of 10 most cited patents of Glaukos:
|Publication Number||Citation Count|
How many inventions of other companies were rejected due to Glaukos patents?
The statistics below share strategic R&D insights. It tells the companies that were trying to protect inventions similar to Glaukos invention. They couldn’t because Glaukos had protected those before them.
Examiners at the USPTO referred 89 Glaukos patents in 516 rejections (35 USC § 102 or 35 USC § 103 types).
The top citing companies in the Glaukos patent portfolio are Alcon, Aquesys Inc and Carl Zeiss.
List of the Companies whose Patents were rejected citing Glaukos –
|Company||Number of Patent Applications that faced Rejection Citing Glaukos Patents||Number of Rejections (102 & 103)|
|Midcap Financial Trust||5||17|
|Verily Life Sciences Llc||5||13|
Count of 102 and 103 Type Rejections based on Glaukos Patents
Top Glaukos Patents used in Rejecting Most Patent Applications
|Patent Number||Count of Rejected Applications|
What Percentage of Glaukos US Patent Applications were Granted?
Glaukos (Excluding its subsidiaries) has filed 128 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 85 have been granted leading to a grant rate of 73.9%.
Below are the key stats of Glaukos patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Glaukos?
|Law Firm||Total Applications||Success Rate|
|Knobbe Martens Olson & Bear Llp||111||74.31%|
|K&L Gates Llp||7||100.00%|
|Eversheds Sutherland Us Llp||4||0.00%|
|Keller Life Science Law Pa||2||0.00%|
|William L Warren||2||0%|
What are Glaukos key innovation segments?
What Technologies are Covered by Glaukos?
The chart below distributes patents filed by Glaukos